Literature DB >> 33319222

Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation.

J N López-Canoa1,2, M Couselo-Seijas2, A Baluja3, L González-Melchor1, A Rozados2, V Llorente-Cortés4,5,6, D de Gonzalo-Calvo4,5,6, J M Guerra6,7, D Vilades7, R Leta7, J L Martínez-Sande1,6, F J García-Seara1,6, X A Fernández-López1, J R González-Juanatey1,2,6, S Eiras2,6, M Rodríguez-Mañero1,2,6.   

Abstract

AIMS: Adiposity plays a key role in the pathogenesis of atrial fibrillation (AF). Our aim was to study the sex differences in adipokines levels according to AF burden. METHODS AND
RESULTS: Two independent cohorts of patients were studied: (i) consecutive patients with AF undergoing catheter ablation (n = 217) and (ii) a control group (n = 105). (i) Adipokines, oxidative stress, indirect autonomic markers, and leucocytes mRNA levels were analysed; (ii) correlation between biomarkers was explored with heatmaps and Kendall correlation coefficients; and (iii) logistic regression and random forest model were used to determine predictors of AF recurrence after ablation. Our results showed that: (i) fatty acid-binding protein 4 (FABP4) and leptin levels were higher in women than in men in both cohorts (P < 0.01). In women, FABP4 levels were higher on AF cohort (20 ± 14 control, 29 ± 18 paroxysmal AF and 31 ± 17 ng/mL persistent AF; P < 0.01). In men, leptin levels were lower on AF cohort (22 ± 15 control, 13 ± 16 paroxysmal AF and 13 ± 11 ng/mL persistent AF; P < 0.01). (ii) In female with paroxysmal AF, there was a lower acetylcholinesterase and higher carbonic anhydrase levels with respect to men (P < 0.05). (iii) Adipokines have an important role on discriminate AF recurrence after ablation. In persistent AF, FABP4 was the best predictor of recurrence after ablation (1.067, 95% confidence interval 1-1.14; P = 0.046).
CONCLUSION: The major finding of the present study is the sex-based differences of FABP4 and leptin levels according to AF burden. These adipokines are associated with oxidative stress, inflammatory and autonomic indirect markers, indicating that they may play a role in AF perpetuation. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Adipokines; Adipose tissue; Atrial fibrillation; Fatty acid-binding protein 4; Gender

Mesh:

Substances:

Year:  2021        PMID: 33319222     DOI: 10.1093/europace/euaa284

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

1.  Targeting Fatty Acid-Binding Protein 4 Improves Pathologic Features of Aortic Stenosis.

Authors:  Mattie Garaikoetxea; Ernesto Martín-Núñez; Adela Navarro; Lara Matilla; Amaya Fernández-Celis; Vanessa Arrieta; Amaia García-Peña; Alicia Gainza; Virginia Álvarez; Rafael Sádaba; Eva Jover; Natalia López-Andrés
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

2.  The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation.

Authors:  José Nicolás López-Canoa; Marinela Couselo-Seijas; Teba González-Ferrero; Cristina Almengló; Ezequiel Álvarez; Adrián González-Maestro; Laila González-Melchor; José Luis Martínez-Sande; Javier García-Seara; Jesús Fernández-López; Bahij Kreidieh; Eva González-Babarro; José Ramón González-Juanatey; Sonia Eiras; Moisés Rodríguez-Mañero
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

3.  Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies.

Authors:  Ruben R De With; Vicente Artola Arita; Bao-Oanh Nguyen; Dominik Linz; Hugo Ten Cate; Henri Spronk; Ulrich Schotten; Anton Jan van Zonneveld; Ömer Erküner; M Agustina Bayón; Anders S Schmidt; Justin G L M Luermans; Harry J G M Crijns; Isabelle C Van Gelder; Michiel Rienstra
Journal:  Europace       Date:  2022-02-02       Impact factor: 5.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.